.
.
.
.
Coronavirus

Vaccine effectiveness will likely drop against Omicron: Moderna CEO

Published: Updated:

The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been against the Delta variant.

For the latest headlines, follow our Google News channel online or via the app.

“There is no world, I think, where (the effectiveness) is the same level . . . we had with Delta,” Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview.

“I think it’s going to be a material drop. I just don’t know how much because we need to wait for the data. But all the scientists I’ve talked to . . . are like ‘this is not going to be good’.”

Read more:

Omicron poses ‘very high’ global health risk, countries must prepare: WHO

UAE residents have mixed feelings about travel amid COVID-19 variant Omicron

First image of Omicron shows many more mutations than Delta variant

Top Content Trending